iQone Healthcare Switzerland

is an independent Swiss specialty pharma company founded in 2013. The company is focused on the commercialization of biosimilars, orphan drugs, and oncology products, operating within the Biotechnology, Health Care, and Pharmaceutical industries. With a slogan of "Boosting access to therapeutic advances through entrepreneurial agility," iQone has established an agile model to expedite the adoption of biosimilars. The company emphasizes the importance of physicians' commitment to the public interest with the tangible choice of biosimilars and the responsibility of prescribing the best available treatment at the best price. iQone Healthcare Switzerland presents an opportunity for investors to be part of a paradigm shift in the pharmaceutical industry and contribute to greater access to therapeutic treatments. As of now, there is no publicly available information on the last investment and the participating investors. Based in Switzerland, iQone Healthcare Switzerland is positioned to make a significant impact in the healthcare and pharmaceutical sectors.